Becton Dickinson and Company (BDX)
$155.27+2.57%
Spriggl Score: Good— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Recurring revenue visibility shines post-spin, yet high leverage caps the re-rating potential for patient investors.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Becton Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public world…
- Sector:
- Healthcare
- Industry:
- Medical Instruments & Supplies
- Market Cap:
- $39.0B
Recent dividends
- 9 Jun 2026$1.05
- 10 Mar 2026$1.05
- 8 Dec 2025$0.83
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Becton Dickinson and Company and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free